Likewise, Alkbh2 knockdown in bladder cancer tissue limited tumour development, while ALKBH2 down-regulation sensitized cells to alkylating agents in glioma9,10 and cisplatin in lung cancer11. This evidence concerns the gene ALKBH2 and urinary bladder carcinoma.